Free-market fiscal conservatives are scratching their heads.
Hope Ahead for VA/DOD Interoperability
In 1982, the Department of Veterans Affairs (VA) and the Department of Defense (DOD) were charged by Congress to share patient information for servicemembers transitioning from DOD into the VA health care system. This transition process has been anything but seamless, with medical records being attached to gurneys each time a patient was moved, and […]
Importing Foreign Drugs Will Not Lower Drug Costs
This morning, the Department of Health and Human Services (HHS) announced a Notice of Proposed Rule Making (NPRM) to review two potential ways to allow “safe” importation of certain drugs originally intended for foreign markets. No secretary of Health and Human Services or commissioner of the Food and Drug Administration (FDA) under a Republican or […]
Kamala Harris’s Medicare for All Plan: Just Another Gateway to Socialized Healthcare
Bottom line: Sen. Harris’s plan is just another entry way to force government-run healthcare on everyone.
Is the Prescription Drug Pricing Reduction Act Another Obamacare?
For weeks, there was little information on what would be in the legislation since it was being discussed and written behind closed doors.
Colorado and California Take Action to Lower Obamacare Premiums
A July 23, 2019 Inside Health Policy healthcare column discusses predictions made by Colorado and California state officials on the cost of their insurance premiums in 2020 due to actions they took to make the Patient Protection and Affordable Care Act (ACA), or Obamacare, more affordable. Colorado applied for a 1332 state innovation waiver that […]
Socialist Drug Price Controls Should be Rejected
It has been often said that in Washington, D.C. bad news comes out on a Friday afternoon and today, July 19, 2019, is no exception
V.P. Biden’s Plan is Really a Side Door to Medicare for All
Today, former Vice President and 2020 Democratic presidential candidate Joe Biden offered his healthcare plan, the “Affordable Care Act 2.0.” It would keep and build on Obamacare and provide a public option or mechanism for people to buy into a government-run plan. Biden says he would provide “free premiums” to low-income people that live in […]
Drug Price Controls Push Innovation Out of the Picture
As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny. Rep. Lloyd Doggett’s (D-Texas) bill, H.R. 1046, the Medicare Negotiation and Competitive Licensing Act, was introduced on February 7, 2019 and has 126 cosponsors in the House. This legislation would […]
CAGW Weighs In on Important Announcements on Drug Pricing
Two important news items regarding pharmaceutical prices have been announced within the past week: a judge’s decision on a Trump administration rule that would have forced drug companies to provide the wholesale acquisition cost (WAC) of a drug in their television ads and a forthcoming executive order concerning drug prices.